Evidence map›Paper›PMID 20689811›Full record

ArticlePloS one2010

A critical tryptophan and Ca2+ in activation and catalysis of TPPI, the enzyme deficient in classic late-infantile neuronal ceroid lipofuscinosis.

Salomon Kuizon, Kathleen DiMaiuta, Marius Walus, Edmund C Jenkins, Marisol Kuizon, Elizabeth Kida, Adam A Golabek, Daniel O Espinoza, Raju K Pullarkat, Mohammed A Junaid

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Ppt1-deficiency dysregulates lysosomal CaJournal of inherited metabolic disease · 2022
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Salomon KuizonDepartment of Developmental Biochemistry, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, United States of America.
Kathleen DiMaiuta
Marius Walus
Edmund C Jenkins
Marisol Kuizon
Elizabeth Kida
Adam A Golabek
Daniel O Espinoza
Raju K Pullarkat
Mohammed A Junaid
New York State Office for People With Developmental Disabilities · US

Funding

NINDS NIH HHS R01 NS047355
6 · The paper itself

Abstract

backgroundTripeptidyl aminopeptidase I (TPPI) is a crucial lysosomal enzyme that is deficient in the fatal neurodegenerative disorder called classic late-infantile neuronal ceroid lipofuscinosis (LINCL). It is involved in the catabolism of proteins in the lysosomes. Recent X-ray crystallographic studies have provided insights into the structural/functional aspects of TPPI catalysis, and indicated presence of an octahedrally coordinated Ca(2+). METHODOLOGY: Purified precursor and mature TPPI were used to study inhibition by NBS and EDTA using biochemical and immunological approaches. Site-directed mutagenesis with confocal imaging technique identified a critical W residue in TPPI activity, and the processing of precursor into mature enzyme. PRINCIPAL

findingsNBS is a potent inhibitor of the purified TPPI. In mammalian TPPI, W542 is critical for tripeptidyl peptidase activity as well as autocatalysis. Transfection studies have indicated that mutants of the TPPI that harbor residues other than W at position 542 have delayed processing, and are retained in the ER rather than transported to lysosomes. EDTA inhibits the autocatalytic processing of the precursor TPPI. CONCLUSIONS/SIGNIFICANCE: We propose that W542 and Ca(2+) are critical for maintaining the proper tertiary structure of the precursor proprotein as well as the mature TPPI. Additionally, Ca(2+) is necessary for the autocatalytic processing of the precursor protein into the mature TPPI. We have identified NBS as a potent TPPI inhibitor, which led in delineating a critical role for W542 residue. Studies with such compounds will prove valuable in identifying the critical residues in the TPPI catalysis and its structure-function analysis.

Indexed as

BiocatalysisAminopeptidasesAnimalsBase SequenceBromosuccinimideCalciumCHO CellsCricetinaeCricetulusDipeptidyl-Peptidases and Tripeptidyl-PeptidasesEnzyme ActivationEnzyme InhibitorsEnzyme PrecursorsHumansIndolesModels, MolecularAminopeptidasesBromosuccinimideCalciumDipeptidyl-Peptidases and Tripeptidyl-PeptidasesEnzyme InhibitorsEnzyme PrecursorsIndolesSerine ProteasesTPP1 protein, humanTripeptidyl-Peptidase 1Tryptophan

Identifiers

PMID20689811
PMCPMC2914745
OpenAlexW2012646463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.